Category

Drug Development Pharma

Alex Karlsson Parra

Immunicum advances its Phase Ib/II combination trial

June 15, 2020

Immunicum has announced that the …

Fredrik Frejd

Affibody terminates program and announces positive data from another

June 15, 2020

Affibody has announced the completion …

Lars Nieba

Betalutin receives positive EMA opinion

May 19, 2020

Nordic Nanovector has announced that …

Klaas Bakker

Oncopeptides announces new data

May 18, 2020

Oncopeptides has announced that data …

Jessica Martinsson

Sprint Bioscience announces positive data

May 5, 2020

Sprint Bioscience has announced that …

Uli Hacksell

Medivir phase II study published in Annals of Internal Medicine

January 22, 2020

Medivir has announced that the …

Idogen

Idogen’s cell technology advanced to large-scale production

January 20, 2020

Idogen has announced that the …

Sana Alajmovic

New study shows Sigrid’s medical device prevents weight gain

January 16, 2020

Sigrid Therapeutics has announced the …

FDA approved

FDA approval for Genmab’s Darzalex in combination with Bortezomib, Thalidomide and Dexamethasone

October 2, 2019

Genmab has announced that the …

Emmanuel Dulac

Zealand Pharma and Boehringer Ingelheim initiate Phase 2 development of BI 456906

September 4, 2019

Boehringer Ingelheim plans to initiate …

Mene Pangalos

FDA grants Fast Track designation for AstraZeneca’s Farxiga

August 28, 2019

The US Food and Drug …

FDA approved

FDA approves Orion’s and Bayer’s darolutamide

August 1, 2019

The approval of darolutamide is …

Xbrane team

Xbrane enters term-sheet with STADA

June 4, 2019

The company has entered a …

Carl-Johan Dalsgaard

Vicore Pharma announces second indication for VP01

April 23, 2019

The company has selected diffuse …

Follicum selects new drug candidate

February 11, 2019

The biotech company reports that …

Nordic Nanovector

Nordic Nanovector has been granted Fast Track designation

June 12, 2018

The US Food & Drug …

1
2
3
···
12